- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 31st, 2006
Ahmedabad-based pharma major Dishman Pharmaceuticals and Chemicals (DPCL) is keen to acquire biotech and nanotechnology contract research organisation (CRO) companies in the US and Europe.
Talking to Business Standard, J R Vyas, MD of Dishman Pharma, said, "We are keen to acquire CROs companies operating in biotech and nanotechnolgy research."
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Scientists find technique to improve carbon superlattices for quantum electronic devices: In a paradigm shift from conventional electronic devices, exploiting the quantum properties of superlattices holds the promise of developing new technologies October 20th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016